MDM2 and cancer: Although our study had limited power to detect modest to moderate increase in risk of cancer by histologic subtype, our results did not show that the observed association was restricted to any specific histologic subtype, which suggests that high-risk genotypes of MDM2 and p14ARF might be an indicator of susceptibility to SGC in general.